They say one in 10 breast cancer patients has too much of the FGFR1 gene.
BBC: Scientists find why tamoxifen fails some breast cancers
The work in the journal Cancer Research suggests the problem is too much of a gene called FGFR1.
Once FGFR1 was stopped, hormone-based treatments like Tamoxifen could get back to work in destroying cancer cells, they found.
This discovery could lead to new treatments for these women as scientists "switch off" the action of FGFR1, enabling Tamoxifen to work.
They introduced a drug which "switched off" the action of FGFR1.
应用推荐
模块上移
模块下移
不移动